Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors
Abstract Esophageal cancer (EC) is an aggressive disease, presenting two main histological subtypes: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). The two EC subtypes widely differ concerning virtually all factors. ESCC development is mainly associated with tobacco and alcohol abuse, wher...
Guardado en:
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Nature Portfolio
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/425da1fa68414c7fbd4cac79e4f3ce71 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:425da1fa68414c7fbd4cac79e4f3ce71 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:425da1fa68414c7fbd4cac79e4f3ce712021-12-02T14:01:32ZLipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors10.1038/s41598-020-80035-42045-2322https://doaj.org/article/425da1fa68414c7fbd4cac79e4f3ce712021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-020-80035-4https://doaj.org/toc/2045-2322Abstract Esophageal cancer (EC) is an aggressive disease, presenting two main histological subtypes: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). The two EC subtypes widely differ concerning virtually all factors. ESCC development is mainly associated with tobacco and alcohol abuse, whereas obesity and chronic gastroesophageal reflux disease (GERD) are important risk factors not only for EAC, but also for for Barrett’s esophagus (BE), an intestinal metaplasia that precedes EAC. Obesity triggers ectopic lipid droplets (LD) accumulation in non-adipose tissues. LD are organelles involved in cell metabolism, signaling, proliferation and production of inflammatory mediators. Therefore, the aim of this work was to investigate LD occurrence and role in EC. This study shows progressive LD levels increase along EAC development, in esophageal samples from non-obese through obese individuals, as well as BE, and EAC patients, whereas no significant changes were observed in ESCC samples, when compared to non-tumor samples. Additionally, in order to mimic BE and EAC risk factors exposure, a non-tumor esophageal cell line was incubated with oleic acid (OA) and acidified medium and/or deoxycholic acid (DCA), revealing a significant increment in LD amount as well as in COX-2 and CXCL-8 expression, and in IL-8 secretion. Further, COX-2 expression and LD amount presented a significant positive correlation and were detected co-localized in EAC, but not in ESCC, suggesting that LD may be the site for eicosanoid production in EAC. In conclusion, this study shows that obesity, and BE- and EAC-associated inflammatory stimuli result in a gradual increase of LD, that may be responsible for orchestrating inflammatory mediators’ production and/or action, thus contributing to BE and EAC genesis and progression.N. CarrossiniN. Meireles Da CostaE. Andrade-BarretoV. P. L. SousaP. Nicolau-NetoP. T. Souza-SantosG. R. MansurL. WernersbachP. T. BozzaJ. P. B. ViolaLuis Felipe Ribeiro PintoNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q N. Carrossini N. Meireles Da Costa E. Andrade-Barreto V. P. L. Sousa P. Nicolau-Neto P. T. Souza-Santos G. R. Mansur L. Wernersbach P. T. Bozza J. P. B. Viola Luis Felipe Ribeiro Pinto Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| description |
Abstract Esophageal cancer (EC) is an aggressive disease, presenting two main histological subtypes: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). The two EC subtypes widely differ concerning virtually all factors. ESCC development is mainly associated with tobacco and alcohol abuse, whereas obesity and chronic gastroesophageal reflux disease (GERD) are important risk factors not only for EAC, but also for for Barrett’s esophagus (BE), an intestinal metaplasia that precedes EAC. Obesity triggers ectopic lipid droplets (LD) accumulation in non-adipose tissues. LD are organelles involved in cell metabolism, signaling, proliferation and production of inflammatory mediators. Therefore, the aim of this work was to investigate LD occurrence and role in EC. This study shows progressive LD levels increase along EAC development, in esophageal samples from non-obese through obese individuals, as well as BE, and EAC patients, whereas no significant changes were observed in ESCC samples, when compared to non-tumor samples. Additionally, in order to mimic BE and EAC risk factors exposure, a non-tumor esophageal cell line was incubated with oleic acid (OA) and acidified medium and/or deoxycholic acid (DCA), revealing a significant increment in LD amount as well as in COX-2 and CXCL-8 expression, and in IL-8 secretion. Further, COX-2 expression and LD amount presented a significant positive correlation and were detected co-localized in EAC, but not in ESCC, suggesting that LD may be the site for eicosanoid production in EAC. In conclusion, this study shows that obesity, and BE- and EAC-associated inflammatory stimuli result in a gradual increase of LD, that may be responsible for orchestrating inflammatory mediators’ production and/or action, thus contributing to BE and EAC genesis and progression. |
| format |
article |
| author |
N. Carrossini N. Meireles Da Costa E. Andrade-Barreto V. P. L. Sousa P. Nicolau-Neto P. T. Souza-Santos G. R. Mansur L. Wernersbach P. T. Bozza J. P. B. Viola Luis Felipe Ribeiro Pinto |
| author_facet |
N. Carrossini N. Meireles Da Costa E. Andrade-Barreto V. P. L. Sousa P. Nicolau-Neto P. T. Souza-Santos G. R. Mansur L. Wernersbach P. T. Bozza J. P. B. Viola Luis Felipe Ribeiro Pinto |
| author_sort |
N. Carrossini |
| title |
Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| title_short |
Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| title_full |
Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| title_fullStr |
Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| title_full_unstemmed |
Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| title_sort |
lipid droplet biogenesis and cox-2 pathway activation are triggered by barrett’s esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors |
| publisher |
Nature Portfolio |
| publishDate |
2021 |
| url |
https://doaj.org/article/425da1fa68414c7fbd4cac79e4f3ce71 |
| work_keys_str_mv |
AT ncarrossini lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT nmeirelesdacosta lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT eandradebarreto lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT vplsousa lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT pnicolauneto lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT ptsouzasantos lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT grmansur lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT lwernersbach lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT ptbozza lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT jpbviola lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors AT luisfeliperibeiropinto lipiddropletbiogenesisandcox2pathwayactivationaretriggeredbybarrettsesophagusandadenocarcinomabutnotesophagealsquamouscellcarcinomariskfactors |
| _version_ |
1718392136285552640 |